Drugs · acquisition-cost intelligence
Fluoxetine
· ingredient fluoxetine· FLUOXETINE HYDROCHLORIDE 20 mg/5mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.20220
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per ML — the trend nobody else shows. 6 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fluoxetine products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.
| Product | NADAC / ML | vs this |
|---|---|---|
| Fluoxetine | $0.03640 | −$0.16580 |
| Fluoxetine | $0.05206 | −$0.15010 |
| Fluoxetine | $0.06677 | −$0.13540 |
| Fluoxetine | $0.07791 | −$0.12430 |
| fluoxetine | $0.08905 | −$0.11310 |
| fluoxetine | $0.22711 | +$0.02490 |
| Olanzapine and Fluoxetine | $4.47 | +$4.27 |
| Fluoxetine Hydrochloride | $30.35 | +$30.15 |
Medicare Part D coverage · CY2026
On 328 plan formularies · typical tier 2
Prior auth 0% · Step therapy 0% · Quantity limit 28% of formularies
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.